Cite
HARVARD Citation
Chuma, M. et al. (2022). Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis. Hepatology research. 52 (3), pp. 269-280. [Online].